Treatment effect of switching from salmeterol/fluticasone to formoterol/budesonide combinations in patients with asthma

Trial Profile

Treatment effect of switching from salmeterol/fluticasone to formoterol/budesonide combinations in patients with asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2013

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 21 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top